Agilent 2100 Bioanalyzer drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (45)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. (2025)
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
- Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
- Nanopore sequencing of RNA and cDNA molecules in . (2022)
- Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
- Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. (2021)
- Joint single-cell measurements of nuclear proteins and RNA in vivo. (2021)
- A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas. (2021)
- Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
- Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X. (2020)
- B cells and tertiary lymphoid structures promote immunotherapy response. (2020)
- ASEP: Gene-based detection of allele-specific expression across individuals in a population by RNA sequencing. (2020)
- Long-term spatial tracking of cells affected by environmental insults. (2020)
- Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
- Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumor. (2019)
- RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. (2019)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
- Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
- Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
- A compendium of conserved cleavage and polyadenylation events in mammalian genes. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
- PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites. (2018)
- Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
- Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. (2018)
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
- Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. (2017)
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
- Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
- Integrative clinical genomics of advanced prostate cancer. (2015)
- Spatial reconstruction of single-cell gene expression data. (2015)
- Robust enumeration of cell subsets from tissue expression profiles. (2015)
- A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. (2014)
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. (2014)
- Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. (2012)
- Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
- Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1. (2011)
- Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. (2011)
- Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. (2010)
- Tackling the widespread and critical impact of batch effects in high-throughput data. (2010)
- Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. (2009)
- RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. (2008)
Merged raw entities (7)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| agilent 2100 bioanalyzer | drug | 28 | 33 |
| agilent | drug | 20 | 24 |
| agilent bioanalyzer | drug | 12 | 15 |
| bioanalyzer | drug | 11 | 16 |
| bioanalyzer 2100 | drug | 9 | 10 |
| agilent bioanalyzer 2100 | drug | 7 | 7 |
| agilent bioanalyzer (agilent technologies usa) | drug | — | — |